30531009|t|Effect of sevoflurane preconditioning on astrocytic dynamics and neural network formation after cerebral ischemia and reperfusion in rats.
30531009|a|Astrocytes, the major component of blood-brain barriers, have presented paradoxical profiles after cerebral ischemia and reperfusion in vivo and in vitro. Our previous study showed that sevoflurane preconditioning improved the integrity of blood-brain barriers after ischemia and reperfusion injury in rats. This led us to investigate the effects of sevoflurane preconditioning on the astrocytic dynamics in ischemia and reperfusion rats, in order to explore astrocytic cell-based mechanisms of sevoflurane preconditioning. In the present study, 2,3,5-triphenyltetrazolium chloride staining and Garcia behavioral scores were utilized to evaluate cerebral infarction and neurological outcome from day 1 to day 3 after transient middle cerebral artery occlusion surgery. Using immunofluorescent staining, we found that sevoflurane preconditioning substantially promoted the astrocytic activation and migration from the penumbra to the infarct with microglial activation from day 3 after middle cerebral artery occlusion. The formation of astrocytic scaffolds facilitated neuroblasts migrating from the subventricular zone to the lesion sites on day 14 after injury. Neural networks increased in the infarct of sevoflurane preconditioned rats, consistent with decreased infarct volume and improved neurological scores after ischemia and reperfusion injury. These findings demonstrate that sevoflurane preconditioning confers neuroprotection, not only by accelerating astrocytic spatial and temporal dynamics, but also providing astrocytic scaffolds for neuroblasts migration to ischemic regions, which facilitates neural reconstruction after brain ischemia.
30531009	10	21	sevoflurane	Chemical	MESH:D000077149
30531009	96	113	cerebral ischemia	Disease	MESH:D002545
30531009	133	137	rats	Species	10116
30531009	238	255	cerebral ischemia	Disease	MESH:D002545
30531009	325	336	sevoflurane	Chemical	MESH:D000077149
30531009	406	414	ischemia	Disease	MESH:D007511
30531009	419	437	reperfusion injury	Disease	MESH:D015427
30531009	441	445	rats	Species	10116
30531009	489	500	sevoflurane	Chemical	MESH:D000077149
30531009	547	555	ischemia	Disease	MESH:D007511
30531009	572	576	rats	Species	10116
30531009	634	645	sevoflurane	Chemical	MESH:D000077149
30531009	685	720	2,3,5-triphenyltetrazolium chloride	Chemical	MESH:C009591
30531009	785	804	cerebral infarction	Disease	MESH:D002544
30531009	866	898	middle cerebral artery occlusion	Disease	MESH:D020244
30531009	956	967	sevoflurane	Chemical	MESH:D000077149
30531009	1072	1079	infarct	Disease	MESH:D007238
30531009	1124	1156	middle cerebral artery occlusion	Disease	MESH:D020244
30531009	1336	1343	infarct	Disease	MESH:D007238
30531009	1347	1358	sevoflurane	Chemical	MESH:D000077149
30531009	1374	1378	rats	Species	10116
30531009	1406	1413	infarct	Disease	MESH:D007238
30531009	1460	1468	ischemia	Disease	MESH:D007511
30531009	1473	1491	reperfusion injury	Disease	MESH:D015427
30531009	1525	1536	sevoflurane	Chemical	MESH:D000077149
30531009	1714	1722	ischemic	Disease	MESH:D002545
30531009	1778	1792	brain ischemia	Disease	MESH:D002545
30531009	Negative_Correlation	MESH:D000077149	MESH:D007511
30531009	Negative_Correlation	MESH:D000077149	MESH:D002545
30531009	Negative_Correlation	MESH:D000077149	MESH:D020244
30531009	Negative_Correlation	MESH:D000077149	MESH:D007238
30531009	Negative_Correlation	MESH:D000077149	MESH:D015427

